/term/bs-deferred-policy-acquisition-costs/TSE:2370 Medinet Co (TSE:2370) Deferred Policy Acquisition Costs
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Deferred Policy Acquisition Costs

Medinet Co (TSE:2370) Deferred Policy Acquisition Costs


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.

Medinet Co (TSE:2370) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Deferred Policy Acquisition Costs
Comparable Companies
TSE:3750 TSE:4891 TSE:7776 TSE:4598 TSE:4588 TSE:4888 TSE:4896 TSE:4572 TSE:4593 TSE:4594 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Website
http://www.medinet-inc.co.jp
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.